AIVITA Biomedical to Participate at Upcoming February and March Aesthetic & Dermatology Conferences

Date: Feb 27, 2018

IRVINE, Calif. – February 27, 2018 – AIVITA Biomedical, a global bio-tech wellness company specializing in novel stem cell applications, announced today its participation in three upcoming aesthetic and dermatology conferences in support of its recently launched ROOT OF SKIN™ and soon-to-launch ROOT OF SKIN™ MD skincare lines.

February 28 through March 3 AIVITA will be exhibiting at the joint Dallas Cosmetic™ Surgery and Medicine Meeting and Dallas Rhinoplasty™ Meeting in Dallas, Texas. AIVITA will preview its upcoming ROOT OF SKIN™ MD line of professional skincare products to an audience of domestic and international cosmetic surgeons and core cosmetic medicine practitioners.

March 1 AIVITA will be demonstrating its consumer ROOT OF SKIN™ brand and select products at the Cosmetic Executive Women (CEW) 2018 Beauty Awards Product Demo at the Metropolitan Pavilion in New York, New York. The Beauty Award Product Demo will be attended by 2,000 CEW members and beauty industry professionals who are defining the future of beauty.

March 1-4 AIVITA will be at the 2018 South Beach Symposium in Miami Beach, Florida. The company will be exhibiting its soon-to-launch ROOT OF SKIN™ MD line of professional skincare products to physicians and aestheticians seeking the newest therapies, technologies and procedures. AIVITA’s Chief Science Officer, Dr. Gabriel Nistor, will present the company’s technology and recent discoveries in a talk entitled Stem Cells and Regenerative Medicine for Skin and Hair, taking place at 5:10pm on Friday, March 2.


ROOT OF SKIN™ is the world’s first skin care product formulated and marketed for use by both women and men. Created by AIVITA Biomedical, the ROOT OF SKIN™ patent-pending proprietary actives complex, SourceCode Technology™, is the result of decades of leading research in human stem cell-based cancer therapies.  SourceCode Technology™ is exclusively manufactured AIVITA Biomedical’s clinical grade research facilities and is available only in ROOT OF SKIN™ products.  100% of proceeds from the sale of ROOT OF SKIN products support the treatment of women with ovarian cancer.

ROOT OF SKIN™.  Style by Science.

About AIVITA Biomedical

AIVITA Biomedical is a privately held company engaged in the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. Founded in 2016 by pioneers in the stem cell industry, AIVITA Biomedical utilizes its expertise in stem cell growth and directed, high-purity differentiation to enable safe, efficient and economical manufacturing systems which support its commercial line of skin care products and therapeutic pipeline.